Reverse genetics systems

Details for Australian Patent Application No. 2010277310 (hide)

Owner Novartis AG

Inventors Dormitzer, Philip; Franti, Michael; Mason, Peter

Agent FB Rice

Pub. Number AU-A-2010277310

PCT Pub. Number WO2011/012999

Priority 61/273,151 31.07.09 US

Filing date 30 July 2010

Wipo publication date 3 February 2011

International Classifications

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

Event Publications

23 February 2012 PCT application entered the National Phase

  PCT publication WO2011/012999 Priority application(s): WO2011/012999

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010277350-Herbicidally active heteroarylsupsilonbstitupsilonted cyclic diones or derivatives thereof

2010277306-Manual too for application of a tile laying device and similar articles on a surface to coat